Hancock Whitney Corp Cuts Stake in Blueprint Medicines Co. (NASDAQ:BPMC)

Hancock Whitney Corp lowered its position in Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) by 10.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 4,526 shares of the biotechnology company’s stock after selling 526 shares during the period. Hancock Whitney Corp’s holdings in Blueprint Medicines were worth $485,000 at the end of […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,United States ,L Becker Hewes ,Ariel Hurley ,Morgan Stanley ,Blueprint Medicines Corporation ,Securities Exchange Commission ,Wellington Management Group ,Nasdaq ,Hancock Whitney Corp ,Boxer Capital ,Blueprint Medicines Co ,William Blair Investment Management ,Holdings Channel ,Fisher Asset Management ,Citigroup ,Blueprint Medicines ,Get Rating ,Whitney Corp ,Management Group ,Blair Investment Management ,Exchange Commission ,Medicines Corporation ,Visit Holdingschannel ,Nasdaq Bpmc ,Bpmc ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,